Market open
The Cooper Companies/$COO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About The Cooper Companies
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Ticker
$COO
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
16,000
Website
COO Metrics
BasicAdvanced
$19B
49.91
$1.96
0.97
-
Price and volume
Market cap
$19B
Beta
0.97
52-week high
$110.66
52-week low
$84.76
Average daily volume
1.4M
Financial strength
Current ratio
1.908
Quick ratio
0.806
Long term debt to equity
35.405
Total debt to equity
35.817
Interest coverage (TTM)
6.31%
Management effectiveness
Return on assets (TTM)
3.69%
Return on equity (TTM)
5.02%
Valuation
Price to earnings (TTM)
49.908
Price to revenue (TTM)
5.026
Price to book
2.43
Price to tangible book (TTM)
8.01
Price to free cash flow (TTM)
67.451
Growth
Revenue change (TTM)
8.41%
Earnings per share change (TTM)
32.43%
3-year revenue growth (CAGR)
10.05%
3-year earnings per share growth (CAGR)
-49.02%
What the Analysts think about COO
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for The Cooper Companies stock.
COO Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
COO Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
COO News
AllArticlesVideos
Resecurity Partners with the Philippine Institute of Cyber Security Professionals (PICSPro) to Enhance Cybersecurity Resilience in the Philippines
Business Wire·2 weeks ago
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
GlobeNewsWire·1 month ago
The Cooper Companies, Inc. (COO) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for The Cooper Companies stock?
The Cooper Companies (COO) has a market cap of $19B as of January 27, 2025.
What is the P/E ratio for The Cooper Companies stock?
The price to earnings (P/E) ratio for The Cooper Companies (COO) stock is 49.91 as of January 27, 2025.
Does The Cooper Companies stock pay dividends?
No, The Cooper Companies (COO) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next The Cooper Companies dividend payment date?
The Cooper Companies (COO) stock does not pay dividends to its shareholders.
What is the beta indicator for The Cooper Companies?
The Cooper Companies (COO) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.